Press Room


    Press Release - March 05, 2001

    Pheromone Sciences Corp's President and CEO, Christopher Neuman, Featured on ROB TV

    Pheromone Sciences Corp's President and CEO, Christopher Neuman, was featured on the Friday, March 2/01 "On The Money" segment of ROB TV. Mr. Neuman was interviewed discussing the anticipated milestones in 2001-2002 for Pheromone Sciences Corp, as well as the status of Pheromone's lead product, the PSC Fertility Monitor(TM).

    Interview Highlights:

    -Pheromone Sciences is developing a platform technology with multiple applications in the areas of human fertility and sexuality. -The Company's PSC Fertility Monitor is a fertility cycle monitoring device for the consumer and professional medical market. Pheromone Sciences is also working on other applications built on the fertility monitor technology platform in addition to exploring the potential of it's synthetic human pheromone analogue PSC Synchronin(TM) for pharmaceutical/therapeutic applications. -U.S. Clinical Trials at two leading academic centers: Duke University in Durham, North Carolina and Thomas Jefferson University Hospital in Philadelphia, Pa. have started. -Early revenue generation is achievable for its Fertility Monitor product line with FDA approval expected to be sought as a non-invasive medical device in the latter part of 2001.

    The interview can be viewed on ROB TV's website at: until Friday, March 9/01. Once on the website home page, to view Mr. Neuman's interview, please first click on "Past Programs" (on the upper left of the home page). Once in the Past Programs field, please scroll over to the Friday column and go down to the "On The Money" segment (2:00pm-3:00pm). By clicking on "Modem" or "High Speed", you will be able to view the full hour segment of "On The Money". Mr. Neuman's interview takes place during the time slot of 14:00 -- 21:00 minutes. Please note that in order to view this interview, you must have Real Player installed in your computer. There is a direct link for this download on the ROB TV website.

    For further information, please contact: Christopher Neuman Ph: (416) 861-9854, ext. 226 Email:

    Nick Borrelly Ph: (604) 872-2012 Email:

    Pheromone Sciences is a biotechnology and medical diagnostics device research and development company that focuses on commercializing technologies in the field of human fertility and sexuality.


    Press Releases from:

    2018 2017 2016 2015 2014 2013 2012

    2011 2010 2009 2008 2007 2006 2005

    2004 2003 2002 2001 2000 1999

    Featured News

    2014, January 22

    Sernova’s Disruptive Regenerative Medicine Technologies Set to Improve the Treatment of Chronic Diseases While Reducing Healthcare Costs


    2012, July 11

    Sernova Corp. developing a tiered approach to the treatment of diabetes

    Publisher: Canadian Investor Magazine
    Author: Rochelle Emnance


    2012, July 30

    Feds back local diabetes discovery

    Publisher: London Free Press
    Author: Norman De Bono

    2012, July 30

    Federal program pumps $3 million into new, London business

    Publisher: The London Free Press

    Author: Norman De Bono

    2010 July 10

    Canada's economic action plan supports business innovators

    Publisher: Federal Economic Development Agency for Southern Ontario


    2007, February 20

    "Transplanted cells may protect against diabetes without forced drug use: An interview with Dr. David White"

    Author: Julie Ickes and James Finch

    2006, October 04

    "Sertoli Cells: Mother nature's anti-rejection drug"

    Author: James Finch

    2006, August 24

    "Mass marketing diabetes reversal; novel xeno-transplants may offer new hope for type 1 diabetics"

    Author: James Finch

    Presentation and Video

    May 03, 2018

    Corporate Presentation

    April 2018

    March 29, 2018

    2018 Financial Report - 1st Quarter

    March 29, 2018

    2018 Management Discussion & Analysis (MD&A) - 1st Quarter

    December 11, 2017

    Clearance by FDA of Sernova's US IND

    Conference call audio recording

    September 11, 2017

    Sernova Fact Sheet

    Subscribe to Sernova News